檢索結果 - Evan J. Lipson

Refine Results
  1. 1
    Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma

    Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma 由 Evan J. Lipson, Charles G. Drake

    出版 2011
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer

    Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer 由 Charles G. Drake, Evan J. Lipson, Julie R. Brahmer

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Immunotherapy for Merkel cell carcinoma: a turning point in patient care

    Immunotherapy for Merkel cell carcinoma: a turning point in patient care 由 Isaac S. Chan, Shailender Bhatia, Howard L. Kaufman, Evan J. Lipson

    出版 2018
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma

    Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma 由 Evan J. Lipson, Mabel A. Bodell, Edward S. Kraus, William H. Sharfman

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis

    Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis 由 Animesh Jain, Evan J. Lipson, William H. Sharfman, Steven R. Brant, Mark Lazarev

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

    Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation 由 Rita E Morales, Alexander N. Shoushtari, Michelle M. Walsh, Priya Grewal, Evan J. Lipson, Richard D. Carvajal

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Antagonists of PD-1 and PD-L1 in Cancer Treatment

    Antagonists of PD-1 and PD-L1 in Cancer Treatment 由 Evan J. Lipson, Patrick M. Forde, Hans-Joerg Hammers, Leisha A. Emens, Janis M. Taube, Suzanne L. Topalian

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  8. 8
    Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade

    Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade 由 Evan J. Lipson, Victor E. Velculescu, Theresa S. Pritchard, Mark Sausen, Drew M. Pardoll, Suzanne L. Topalian, Luis A. Díaz

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

    Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade 由 Evan J. Lipson, Mohammed Lilo, Aleksandra Ogurtsova, Jessica Esandrio, Haiying Xu, Patricia Brothers, Megan D. Schollenberger, William H. Sharfman, Janis M. Taube

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat

    Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat 由 Erin E. Resch, Stavriani C. Makri, Paola Ghanem, Ezra Baraban, Kenneth J. Cohen, Alan R. Cohen, Evan J. Lipson, Christine A. Pratilas

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer

    Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer 由 T.J. Williams, David Benavides, Kelly-Ann Patrice, Josep Dalmau, Alexandre Avila, Dung T. Le, Evan J. Lipson, John C. Probasco, Ellen M. Mowry

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series

    Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series 由 Jaclyn LoPiccolo, Megan D. Schollenberger, Sumia Dakhil, Samuel Rosner, Osama Ali, William H. Sharfman, Ann W. Silk, Shailender Bhatia, Evan J. Lipson

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen

    Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen 由 Laura C. Cappelli, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Lei Zheng, Clifton O. Bingham, Ami A. Shah

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Tumor Regression and Allograft Rejection after Administration of Anti–PD-1

    Tumor Regression and Allograft Rejection after Administration of Anti–PD-1 由 Evan J. Lipson, Serena M. Bagnasco, Jack Moore, Sekwon Jang, Manisha J. Patel, Andrea A. Zachary, Drew M. Pardoll, Janis M. Taube, Charles G. Drake

    出版 2016
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  15. 15
    Cardiovascular toxicities associated with immune checkpoint inhibitors

    Cardiovascular toxicities associated with immune checkpoint inhibitors 由 Jiun‐Ruey Hu, Roberta Florido, Evan J. Lipson, Jarushka Naidoo, Reza Ardehali, Carlo G. Tocchetti, Alexander R. Lyon, Robert F. Padera, Douglas B. Johnson, Javid J. Moslehi

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  16. 16
    Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

    Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy 由 Lucie Heinzerling, Patrick A. Ott, F. Stephen Hodi, Aliya N. Husain, Azadeh Tajmir-Riahi, Hussein A. Tawbi, Matthias Pauschinger, Thomas F. Gajewski, Evan J. Lipson, Jason J. Luke

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

    Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series 由 Kendall F. Moseley, Jarushka Naidoo, Clifton O. Bingham, Michael A. Carducci, Patrick M. Forde, Geoffrey T. Gibney, Evan J. Lipson, Ami A. Shah, William H. Sharfman, Laura C. Cappelli

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point<sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced Melanoma

    Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point<sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced Melanoma 由 Steve Y. Cho, Evan J. Lipson, Hyung‐Jun Im, Steven P. Rowe, Esther Mena Gonzalez, Amanda L. Blackford, Alin Chirindel, Drew M. Pardoll, Suzanne L. Topalian, Richard L. Wahl

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

    Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation 由 Tawnie Braaten, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Megan D. Schollenberger, Lei Zheng, Clifton O. Bingham, Ami A. Shah, Laura C. Cappelli

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival

    PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival 由 Evan J. Lipson, Jeremy Vincent, Myriam Loyo, Luciane T. Kagohara, Brandon Luber, Hao Wang, Haiying Xu, Suresh K. Nayar, Timothy S. Wang, David Sidransky, Robert A. Anders, Suzanne L. Topalian, Janis M. Taube

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: